Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Antoine

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 1998
[The role of new drugs in the treatment of locally advanced urothelial tumors of the bladder]E C Antoine, D Khayat
Cancer Chemotherapy and Pharmacology|January 1, 1996
European School of Oncology European consensus on the use of granulocyte colony-stimulating factor: the example of breast cancerE C Antoine, D Khayat
Artificial Intelligence in Medicine|March 22, 2001
ONCODOC: a successful experiment of computer-supported guideline development and implementation in the treatment of breast cancerB Séroussi, J Bouaud, E C Antoine
Proceedings. AMIA Symposium|November 24, 1999
Users' evaluation of OncoDoc, a breast cancer therapeutic guideline delivered at the point of careB Séroussi, J Bouaud, E C Antoine
Cytokines, Cellular & Molecular Therapy|January 5, 2001
Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expression in advanced melanoma patientsR Mouawad, E C Antoine, D Khayat, et al.
Studies in Health Technology and Informatics|October 18, 2001
A before-after study using OncoDoc, a guideline-based decision support-system on breast cancer management: impact upon physician prescribing behaviourJ Bouaud, B Séroussi, E C Antoine, et al.
Melanoma Research|August 10, 2002
Serum caspase-1 levels in metastatic melanoma patients: relationship with tumour burden and non-response to biochemotherapyR Mouawad, E-C Antoine, M Gil-Delgado, et al.
Oncology (Williston Park, N.Y.)|May 12, 2001
The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancerD Khayat, M Gil-Delgado, E C Antoine, et al.
The British Journal of Dermatology|August 22, 2000
A comparative study of Fas and Fas-ligand expression during melanoma progressionC Soubrane, R Mouawad, E C Antoine, et al.
Melanoma Research|June 25, 1999
Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?R Mouawad, D Khayat, S Merle, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 28, 1998
[The role of new drugs in the treatment of locally advanced urothelial tumors of the bladder]E C Antoine, D Khayat
Cancer Chemotherapy and Pharmacology|January 1, 1996
European School of Oncology European consensus on the use of granulocyte colony-stimulating factor: the example of breast cancerE C Antoine, D Khayat
Artificial Intelligence in Medicine|March 22, 2001
ONCODOC: a successful experiment of computer-supported guideline development and implementation in the treatment of breast cancerB Séroussi, J Bouaud, E C Antoine
Proceedings. AMIA Symposium|November 24, 1999
Users' evaluation of OncoDoc, a breast cancer therapeutic guideline delivered at the point of careB Séroussi, J Bouaud, E C Antoine
Cytokines, Cellular & Molecular Therapy|January 5, 2001
Effect of endogenous interleukin-6 on Fas (APO-1/CD95) receptor expression in advanced melanoma patientsR Mouawad, E C Antoine, D Khayat, et al.
Studies in Health Technology and Informatics|October 18, 2001
A before-after study using OncoDoc, a guideline-based decision support-system on breast cancer management: impact upon physician prescribing behaviourJ Bouaud, B Séroussi, E C Antoine, et al.
Melanoma Research|August 10, 2002
Serum caspase-1 levels in metastatic melanoma patients: relationship with tumour burden and non-response to biochemotherapyR Mouawad, E-C Antoine, M Gil-Delgado, et al.
Oncology (Williston Park, N.Y.)|May 12, 2001
The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancerD Khayat, M Gil-Delgado, E C Antoine, et al.
The British Journal of Dermatology|August 22, 2000
A comparative study of Fas and Fas-ligand expression during melanoma progressionC Soubrane, R Mouawad, E C Antoine, et al.
Melanoma Research|June 25, 1999
Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?R Mouawad, D Khayat, S Merle, et al.
Pageof 3